Exploring Thiazole‐Based Heterocycles: Synthesis, Bioactivity, and Molecular Docking for Antimicrobial Applications
Chemical Biology & Drug Design · 2025-05 · 105 (5)
DOI: 10.1111/cbdd.70124 ↗At a glance
Journal article in Chemical Biology & Drug Design, published online on 2025-05-21. Written by Hana M Abumelha and 7 co-authors. Institution: Department of Chemistry, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia. Major MEDLINE topics: Thiazoles, Heterocyclic Compounds, Anti-Infective Agents, Anti-Bacterial Agents. Cited 9 times so far (Crossref); 54 references. Funded by: Deanship of Scientific Research, Princess Nourah Bint Abdulrahman University.
Abstract (original language)
In response to the rising threat of antimicrobial resistance, a novel series of thiazole‐based heterocyclic compounds incorporating benzimidazole, benzoxazole, and benzothiazole via the reaction of 2‐chloro‐N‐(4‐(6‐methyl‐2,4‐dioxo‐3,4‐dihydro‐2H‐pyran‐3‐yl)thiazol‐2‐yl) acetamide (3) with some mercapto derivatives. Pyrazolo[1,5‐ a ]pyrimidine motifs were synthesized via the reaction of aminopyrazole derivative 9 with some electrophilic reagents and systematically characterized. The antimicrobial potential of these molecules was assessed against Staphylococcus aureus , Escherichia coli , and Candida albicans . Among the tested derivatives, compounds 6 , 20 , and 22 emerged as particularly effective, with minimum inhibitory concentrations (MICs) reaching as low as 3.125 μg/mL. Structure–activity relationship (SAR) analysis highlighted the role of electron‐withdrawing groups in enhancing bioactivity. Molecular docking studies further supported the experimental findings, showing favorable interactions with bacterial DNA gyrase (PDB ID: 1KZN). Additionally, SwissADME profiling revealed that the compounds possess promising drug‐like properties and oral bioavailability. These findings position the synthesized thiazole‐containing scaffolds as promising candidates for future antimicrobial drug development.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Chemistry, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
- Department of Biology, College of Science, Taibah University, Al-Madinah, Saudi Arabia.
- Department of Biology/Genetic and Molecular Biology Central Laboratory (GMCL), Jamoum University College, Umm Al-Qura University, Makkah, Saudi Arabia.
- Department of Pharmaceutical Science, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
- Department of Chemistry, Faculty of Science, University of Tabuk, Tabuk, Saudi Arabia.
- Department of Physical Sciences, Chemistry Division, College of Science, Jazan University, Jazan, Saudi Arabia.
ORCID profiles: Abdulmajeed F Alrefaei, Nashwa M El-Metwaly
Funding
- Deanship of Scientific Research, Princess Nourah Bint Abdulrahman University
Cite
APA
Abumelha, H. M., Sefrji, F. O., Alrefaei, A. F., Mojally, M., Alotaibi, F. A., Alomari, K. B., Madkhaly, F. M., & El-Metwaly, N. M. (2025). Exploring Thiazole‐Based Heterocycles: Synthesis, Bioactivity, and Molecular Docking for Antimicrobial Applications. Chemical Biology & Drug Design, 105(5). https://doi.org/10.1111/cbdd.70124
Vancouver
Abumelha HM, Sefrji FO, Alrefaei AF, Mojally M, Alotaibi FA, Alomari KB, et al. Exploring Thiazole‐Based Heterocycles: Synthesis, Bioactivity, and Molecular Docking for Antimicrobial Applications. Chemical Biology & Drug Design. 2025;105(5). doi:10.1111/cbdd.70124
BibTeX
@article{Abumelha2025,
author = {Abumelha, Hana M and Sefrji, Fatmah O and Alrefaei, Abdulmajeed F and Mojally, Mariam and Alotaibi, Fatimah A and Alomari, Khadra B and Madkhaly, Fatimah M and El-Metwaly, Nashwa M},
title = {Exploring Thiazole‐Based Heterocycles: Synthesis, Bioactivity, and Molecular Docking for Antimicrobial Applications},
journal = {Chemical Biology & Drug Design},
year = {2025},
volume = {105},
number = {5},
doi = {10.1111/cbdd.70124}
}
EUVIMED